IAC Express 2011 |
|
Issue number 943: July 25, 2011 |
|
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- Reminder:
IAC launched a major redesign of www.immunize.org
- FDA
approves the 2011-12 influenza vaccine formulation for manufacturers
licensed to produce and distribute influenza vaccine in the U.S.
- IAC's
Video of the Week features a mother's account of her daughter's poor
outcome from measles--wishes she had vaccinated her
- Nominate
an outstanding person for an ECBT Immunization Award--application deadline
is August 15
- WHO
publishes report on rotavirus vaccine and intussusception
- MMWR
announces the first official World Hepatitis Day will be held on July 28
- MMWR
reports on sexual transmission of hepatitis C virus among HIV-infected men
who have sex with men
- CDC
website posts presentation slide sets from the June 2011 ACIP meeting
- New: CDC
issues VIS for adenovirus vaccine
- IAC's
popular laminated versions of the 2011 U.S. immunization schedules are
available. Order a supply for your workplace today!
-
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
- New
Jersey Immunization Network's webinar on adolescent immunization scheduled
for August 10
-
Louisiana's Shots for Tots immunization conference set for October 27-28
in New Orleans
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 943: July 25, 2011 |
|
|
1. |
Reminder: IAC launched a major redesign of www.immunize.org
IAC has launched a major redesign of its website
for healthcare professionals,
www.immunize.org The newly designed website offers you a deeper and
broader experience through improved design and navigation, making it faster
and easier for you to find the essential information that you want and have
come to expect from IAC. To see the improvements that have taken place,
please visit http://www.immunize.org
today!
The new design includes drop-down menus of six major sections on immunize.org.
Also, new sections include Clinic Resources, News and Information, Featured
Resources, A to Z Index, and more.
We hope you have a chance to explore the redesigned
http://www.immunize.org If you are
interested in providing feedback about the new redesign, we would love to
hear your comments. Please complete our brief survey at
http://www.surveymonkey.com/s/SX5RMD6
Back to top |
|
|
2. |
FDA approves the 2011-12 influenza vaccine formulation for manufacturers
licensed to produce and distribute influenza vaccine in the U.S.
On July 18, CDC issued a press release announcing
it has
approved the 2011-12 influenza vaccine formulation. Portions
of the press release are reprinted below.
The U.S. Food and Drug Administration announced today that
it has approved the 2011-2012 influenza vaccine formulation
for all six manufacturers licensed to produce and distribute
influenza vaccine for the United States.
Vaccination remains the cornerstone of preventing influenza,
a contagious respiratory disease caused by influenza
viruses. The vaccine formulation protects against the three
virus strains that surveillance indicates will be most
common during the upcoming season and includes the same
virus strains used for the 2010-2011 influenza season.
On average, between 5 percent and 20 percent of the U.S.
population develops influenza each year, leading to more
than 200,000 hospitalizations from related complications,
according to the U.S. Centers for Disease Control and
Prevention (CDC). Influenza-related deaths vary yearly,
ranging from a low of about 3,000 to a high of 49,000
people. . . .
The brand names and manufacturers of the vaccines for the
upcoming season are: Afluria, CSL Limited; Fluarix,
GlaxoSmithKline Biologicals; FluLaval, ID Biomedical
Corporation; FluMist, MedImmune Vaccines Inc.; Fluvirin,
Novartis Vaccines and Diagnostics Limited; and Fluzone,
Fluzone High-Dose and Fluzone Intradermal, Sanofi Pasteur
Inc. Fluzone Intradermal, approved on May 9, 2011, will be
available for those ages 18 years through 64 years. This
vaccine is delivered into the skin, rather than the muscle,
using a very small needle. . . .
To access the press release, go to:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm263319.htm
Back to top |
|
|
3. |
IAC's Video of the Week features a mother's account of her daughter's poor
outcome from measles--wishes she had vaccinated her
IAC encourages IAC Express readers to watch
"Rachel's
Story," a 4-minute video of a mother describing the extreme
sickness, hospitalization, and permanent hearing loss her 3-year-old daughter experienced after she contracted measles
at a birthday party. The video was developed by the United
Kingdom's National Health Service.
The video will be available on the home page of IAC's
website through July 31. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week.
Remember to bookmark IAC's home page to view a new video
every Monday.
To access the archives of IAC's Videos of the Week, go to:
http://www.immunize.org/votw
Back to top |
|
|
4. |
Nominate an outstanding person for an ECBT Immunization Award--application
deadline is August 15
At its 20th Anniversary Gala, which will be held
in
Washington, DC, on October 11, Every Child By Two (ECBT)
will present awards to three individuals for achievement,
leadership, and overall excellence in the field of
immunization. The application deadline is 5PM ET, August 15.
Awards will be given in three categories:
-
Martin H. Smith, MD, Award for Achievement in Childhood
Immunization--to be presented to a physician who is
dedicated to ensuring access to immunization for all
children
-
ECBT Immunization Leadership Award--to be presented to an
individual working at the national level who has shown
leadership in the field of immunization
-
ECBT Immunization Champion Award--to be presented to an
individual working at the state or local level who has shown
leadership in the field of immunization
The online application form lists the criteria for each
award and provides complete instructions. To access it, go
to: http://ecbt.org/gala/ecbtgalanom.doc
Email entries to Dena Penner at dena@ecbt.org; address
questions to her at the same email address. Alternatively,
fax entries to ECBT at (202) 783-7042.
Back to top |
|
|
5. |
WHO publishes report on rotavirus vaccine and intussusception
On July 22, the WHO publication Weekly
Epidemiological
Record (WER) published "Rotavirus Vaccine and
Intussusception: Report from an expert consultation." To
access the report, go to: http://www.who.int/wer/2011/wer8630.pdf
Back to top |
|
|
6. |
MMWR announces the first official World Hepatitis Day will be held on July 28
CDC published "World Hepatitis Day--July 28,
2011" in the
July 22 issue of MMWR. The article is reprinted below,
excluding references.
July 28, 2011, marks the first official World Hepatitis Day
established by the World Health Organization (WHO). CDC
joins with WHO in calling for a renewed commitment against a
largely silent but persistent epidemic. Worldwide, nearly
500 million persons are living with chronic hepatitis B
virus or hepatitis C virus (HCV) infections, and these
infections cause approximately 1 million deaths annually;
most persons with chronic viral hepatitis are unaware of
their infections. Effective tools are available to prevent
infection with viral hepatitis, including hepatitis B
vaccination, surveillance, education, screening, and
treatment; the challenge is to build the capacity to extend
these interventions globally. In 2010, the World Health
Assembly passed a resolution urging greater control of viral
hepatitis.
In Europe, HCV infection outbreaks and rising incidence have
been observed among men who have sex with men (MSM) with
human immunodeficiency virus (HIV) infection. This issue of
MMWR includes a report on sexual transmission of HCV among
HIV-infected MSM in New York City. The findings emphasize
the importance of HCV screening among these men, which
allows for preventive care and treatment.
In the United States, World Hepatitis Day will be observed
July 28 at a White House event. Information regarding the
webcast of this event will be available at
http://www.cdc.gov/hepatitis
To access the article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6028a1.htm
Back to top |
|
|
7. |
MMWR reports on sexual transmission of hepatitis C virus among HIV-infected
men who have sex with men
CDC published "Sexual Transmission of Hepatitis C
Virus
Among HIV-Infected Men Who Have Sex with Men--New York City,
2005-2010" in the July 22 issue of MMWR. A press summary of
the article is reprinted below.
The role of sexual transmission of hepatitis C virus (HCV)
has not been well-understood, but a new study from New York
City now provides evidence of sexual transmission of HCV
among men who have sex with men (MSM) who also are living
with HIV.
HCV transmission primarily occurs through percutaneous
exposure to blood, and persons who inject drugs are at
greatest risk. After observing a large increase in the
number of new cases of HCV transmission among HIV-infected
MSM, investigators at Mount Sinai Medical Center, along with
CDC, took a closer look to examine the role of sexual
transmission among these men; none had other risk factors
for HCV infection, including injection drug use. Researchers
found that men co-infected with HIV and HCV were
significantly more likely to engage in high-risk sexual
behaviors and non-injection drug use during sex. In
addition, HCV genetic analysis suggested that HCV was
transmitted within social networks of these men. The
findings are particularly concerning because research has
shown that infection with HIV may lead to an increased
likelihood of sexual transmission of HCV and accelerate HCV
disease progression. HCV testing for all HIV-infected MSM is
critical, especially for men engaging in high-risk behavior.
Clinicians should remind patients that unprotected sex
between HIV-infected partners can transmit other infections,
including HCV.
To access the full article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6028a2.htm
Back to top |
|
|
8. |
CDC
website posts presentation slide sets from the June 2011 ACIP meeting
The CDC website recently posted the PowerPoint
slide sets
presented at the June 22-23 ACIP meeting. To access the
slide sets, go to:
http://www.cdc.gov/vaccines/recs/acip/slides-jun11.htm
Back to top |
|
|
9. |
New:
CDC issues VIS for adenovirus vaccine
On July 14, CDC issued the VIS for adenovirus
vaccine. The
vaccine, which is intended for use only among military
personnel age 17-50 years, was licensed by FDA on March 16,
2011.
To access the VIS for adenovirus vaccine, go to:
http://www.immunize.org/vis/vis_adenovirus.pdf
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
|
|
10. |
IAC's popular laminated versions of the 2011 U.S. immunization schedules are
available. Order a supply for your workplace today!
IAC's laminated versions of the 2011 U.S.
child/teen and
adult immunization schedules are covered with a tough,
washable coating that lets them stand up to a year's worth
of use in every area of your workplace where immunizations
are given. Each has six pages (i.e., three double-sided
pages) and is folded to measure 8.5" by 11".
Laminated schedules are printed in color for easy reading,
come complete with essential tables and footnotes, and
include contraindications and precautions--a feature that
will help you make an on-the-spot determination about the
safety of vaccinating patients of any age.
PRICING
1-4 copies: $7.50 each
5-19 copies: $5.50 each
20-99 copies: $4.50 each
To view images of the laminated schedules, or to order
online or download an order form, go to:
http://www.immunize.org/shop/laminated-schedules.asp
For quotes on customizing or placing orders in excess of 999
schedules, call (651) 647-9009 or email
admininfo@immunize.org
To learn about other essential immunization resources
available for purchase from IAC, go to:
http://www.immunize.org/shop
Back to top |
|
|
11. |
Award-winning DVD! "Immunization Techniques: Best Practices with Infants,
Children, and Adults"--from the California Department of Public Health,
Immunization Branch
The California Department of Public Health (CDPH),
Immunization Branch, has updated its award-winning training
video, "Immunization Techniques: Best Practices with
Infants, Children, and Adults." The 25-minute program can be
used to train new employees and to refresh the skills of
experienced staff. The video demonstrates the skills and
techniques needed to administer vaccines to patients of all
ages.
Prices start at $17 each for 1-9 copies and are greatly
reduced for large orders, dropping to $3 each for 1,000-1,499 copies.
To learn more about the DVD, and find out how to order it,
go to: http://www.immunize.org/dvd
For quotes on larger quantities, call (651) 647-9009 or
email admininfo@immunize.org
The Immunization Action Coalition is the only nationwide
vendor of the DVD.
Note for healthcare settings located in California: Contact
your local health department immunization program for a free
copy.
Back to top |
|
|
12. |
New Jersey Immunization Network's webinar on adolescent immunization
scheduled for August 10
The New Jersey Immunization Network's webinar
"Adolescent
Immunization: Strategies for Protecting Our Teens" is
scheduled for August 10 from noon to 1PM ET. The speaker is
Margaret Fisher, MD, FAAP, medical director, Children's
Hospital at Monmouth Medical Center.
For more information on the webinar and to register for it,
go to: https://www2.gotomeeting.com/register/331984307
Back to top |
|
|
13. |
Louisiana's Shots for Tots immunization conference set for October 27-28 in
New Orleans
Louisiana's 19th annual Shots for Tots conference
will be
held in New Orleans on October 27-28. Featured speakers
include Paul Offit, MD, who will speak on the threats posed
by the anti-vaccine movement, and CDC's Yabo Beysolow, MD,
MPH, FAAP, who will give the 2011 CDC update. Dr. Offit is
director of the Vaccine Education Center at Children's
Hospital of Philadelphia.
To access the conference brochure, which includes a mail-in
registration form, go to:
http://www.shotsfortots.com/19thShotsConference.pdf
Back to top |
|
|
|